<a href="https://www.fiercebiotech.com/ai-and-machine-learning/novartis-ceo-vas-narasimhan-joins-anthropic-board-pharmas-link-ai-deepens" hreflang="en">Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen</a>
fiercebiotech.com·Apr 15, 2026
Anthropic has appointed Novartis CEO Vas Narasimhan to its board, highlighting the growing connection between the pharmaceutical industry and Silicon Valley.
The appointment of Novartis CEO Vas Narasimhan to Anthropic's board signals a strategic collaboration between AI innovation and the pharmaceutical sector, suggesting a potential acceleration in AI-driven drug discovery and digital health solutions. For someone tracking healthtech and AI drug discovery, this highlights a valuable opportunity to explore partnerships or investments at the intersection of AI and pharmaceuticals.